- Integration
- The FDA package describes contrast-enhanced CT input, live fluoroscopy, 2D-3D registration using vertebral anatomy, stored roadmaps and snapshots, and application of DICOM standards.
FDA source Exact FDA submission Checked 2026-09-04
This is the interface boundary described in the exact FDA package; current local compatibility, routing, identity, archive, and downtime behavior still require acceptance testing.
- Deployment and data flow
- The FDA package describes a software-only solution with cloud communication, storage, and processing accessed over private networks or the public Internet and recommended hardware; current provider, hosting, contract, availability, and security details remain unverified.
FDA source Exact FDA submission Checked 2026-09-04
This is the release-level boundary described in the exact FDA package; current hosting, contracts, security, availability, upgrade path, and site configuration remain separate evidence.
- Security and privacy
- Not established in reviewed sources
Reviewed sources checked Exact FDA submission Checked 2026-09-04
Public materials reviewed for this exact release do not establish the complete security posture. Request data-flow, identity, audit, encryption, retention, remote-access, vulnerability-management, backup, and incident-response evidence.
- Training and support
- Only trained physicians and qualified endovascular procedure staff should operate or interpret the product. Local onboarding should cover the exact release, supported population, limitations, failure examples, escalation, downtime, and competency documentation.
FDA source Exact FDA submission Checked 2026-09-04
- Monitoring and change control
- Monitor K160088 by exact hardware, software, model, and algorithm version; patient population; anatomy; protocol; operator; input quality; output edits or overrides; failed studies; repeat acquisition or rework; downstream impact; downtime; incidents; recalls; and updates. Track these product-specific limits: Use is limited to the labeled lower-thorax, abdomen, pelvis, and vascular procedures; the FDA material excludes X-ray-guided procedures in the liver, kidneys, and pelvic organs.
FDA source Exact FDA submission Checked 2026-09-04
This is buyer-facing monitoring guidance derived from the exact cleared or authorized scope; it is not a claim that the FDA package provides a live monitoring service.
Release and scope verification
Map installed model, build, options, population, anatomy, inputs, outputs, and enabled functions to K160088 before acceptance.
exact submission · checked 2026-09-04 Later product-family features are not evidence that this cleared or authorized release includes them.
Deployment boundary
The FDA package describes a software-only solution with cloud communication, storage, and processing accessed over private networks or the public Internet and recommended hardware; current provider, hosting, contract, availability, and security details remain unverified.
exact submission · checked 2026-09-04 FDA-described deployment boundaries do not establish current hosting contracts, security controls, uptime, or local qualification.
Interoperability acceptance
The FDA package describes contrast-enhanced CT input, live fluoroscopy, 2D-3D registration using vertebral anatomy, stored roadmaps and snapshots, and application of DICOM standards.
exact submission · checked 2026-09-04 Test representative identifiers, orientation, geometry, measurements, units, routing, failure handling, and round trips locally.
Clinical acceptance
Use a signed local test set for the supported population and workflow. Include common and difficult cases, exclusions, acquisition variation, failed or low-quality inputs, reviewer overrides, and downstream effects. Use is limited to the labeled lower-thorax, abdomen, pelvis, and vascular procedures; the FDA material excludes X-ray-guided procedures in the liver, kidneys, and pelvic organs.
exact submission · checked 2026-09-04 Define stop-use, escalation, rollback, and revalidation triggers before production use.
Economic evaluation
Model capital and recurring cost against net staff time after review, throughput, repeat imaging or rework, room time, consumables, infrastructure, training, service, downtime, upgrade, and replacement costs.
product family · checked 2026-09-04 No exact-product price was found in the reviewed public material; productivity or value claims require local evidence.
Lifecycle monitoring
Monitor K160088 by exact hardware, software, model, and algorithm version; patient population; anatomy; protocol; operator; input quality; output edits or overrides; failed studies; repeat acquisition or rework; downstream impact; downtime; incidents; recalls; and updates. Track these product-specific limits: Use is limited to the labeled lower-thorax, abdomen, pelvis, and vascular procedures; the FDA material excludes X-ray-guided procedures in the liver, kidneys, and pelvic organs.
exact submission · checked 2026-09-04 Revalidate after material software, hardware, model, protocol, interface, or clinical-policy changes. fluoroscopy-guided vascular image-navigation software limits remain submission-specific.